EUVIMEDEUVIMED entdecken
Open Access

Interval Cancers after Negative Screening Contrast-enhanced Mammography

Tali Amir iD, Carol H Lee iD, Sarah Eskreis-Winkler iD, Molly P Hogan iD, Noam Nissan iD, Varadan Sevilimedu iD, Victoria L Mango, Kimberly N Feigin iD, Maxine S Jochelson iD, Christopher E Comstock iD, Janice S Sung iD

Radiology: Imaging Cancer · 01.05.2026 · 8 (3)

DOI: 10.1148/rycan.250559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology: Imaging Cancer, erschienen am 01.05.2026. Verfasst von Tali Amir und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065. Hauptthemen laut MEDLINE: Breast Neoplasms, Early Detection of Cancer, Mammography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients undergoing screening contrast-enhanced mammography, the interval cancer rate was 2.29 cancers per 1000 examinations, and invasive interval cancers were associated with moderate or marked background parenchymal enhancement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEarly Detection of CancerMammographyHumansFemaleAdultRetrospective StudiesMass Screening

Stichwörter der Autor:innen

BreastInterval CancersMammography

Autor:innen und Institutionen

  • Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065.
  • Department of Radiology, Sheba Medical Center, Tel Hashomer, Israel.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Breastlink Women's Imaging, RADNET Beverly Hills, Los Angeles, Calif.
  • Department of Radiology, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY.
  • Department of Radiology, Columbia University, New York, NY.

ORCID-Profile: Tali Amir, Carol H Lee, Sarah Eskreis-Winkler, Molly P Hogan, Noam Nissan, Varadan Sevilimedu, Kimberly N Feigin, Maxine S Jochelson, Christopher E Comstock, Janice S Sung

Förderung

  • NCI NIH HHS
  • NIH
  • NCI

Zitieren

APA

Amir, T., Lee, C. H., Eskreis-Winkler, S., Hogan, M. P., Nissan, N., Sevilimedu, V., Mango, V. L., Feigin, K. N., Jochelson, M. S., Comstock, C. E., & Sung, J. S. (2026). Interval Cancers after Negative Screening Contrast-enhanced Mammography. Radiology: Imaging Cancer, 8(3). https://doi.org/10.1148/rycan.250559

Vancouver

Amir T, Lee CH, Eskreis-Winkler S, Hogan MP, Nissan N, Sevilimedu V, et al. Interval Cancers after Negative Screening Contrast-enhanced Mammography. Radiology: Imaging Cancer. 2026;8(3). doi:10.1148/rycan.250559

BibTeX
@article{Amir2026,
  author = {Amir, Tali and Lee, Carol H and Eskreis-Winkler, Sarah and Hogan, Molly P and Nissan, Noam and Sevilimedu, Varadan and Mango, Victoria L and Feigin, Kimberly N and Jochelson, Maxine S and Comstock, Christopher E and Sung, Janice S},
  title = {Interval Cancers after Negative Screening Contrast-enhanced Mammography},
  journal = {Radiology: Imaging Cancer},
  year = {2026},
  volume = {8},
  number = {3},
  doi = {10.1148/rycan.250559}
}
Kostenlos starten →